Zentalis Pharmaceuticals
ZNTL
$10.71
Share price
-9.00%
Change (1 day)
-50.19%
Change (1 year)
Categories
Earnings for Zentalis Pharmaceuticals (ZNTL)
Earnings in 2023 (TTM): -$0.28 B
According to Zentalis Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.28 B. In 2022 the company made an earning of -$0.23 B a decrease over its 2021 earnings that were of -$0.17 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Zentalis Pharmaceuticals from 2019 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.28 B | 25.12% |
| 2022 | -$0.23 B | 34.48% |
| 2021 | -$0.17 B | 39.33% |
| 2020 | -$0.12 B | 154.74% |
| 2019 | -$46.37 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.19 B | -33.43% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$18.95 M | -93.16% | 🇺🇸 USA |